De Mattia D - Search Results

1

Compliance with iron-chelation treatment after bone marrow transplantation.

Schettini F, De Mattia D, Sabato V, Del Vecchio GC. Schettini F, et al. Among authors: de mattia d. Lancet. 1994 Mar 5;343(8897):604. Lancet. 1994. PMID: 7906359 No abstract available.

2

[Nuclear magnetic resonance and iron overload in thalassemia].

Schettini F, De Mattia D, Cavallo L, Sabato V, Santoro N, Del Vecchio GC, Martinelli G, Martinelli A, Di Bartolomeo P, Di Girolamo G. Schettini F, et al. Among authors: de mattia d. Minerva Pediatr. 1991 Dec;43(12):777-81. Minerva Pediatr. 1991. PMID: 1798402 Italian.

3

Bone marrow transplantation in a case of severe, type II congenital dyserythropoietic anaemia (CDA II).

Iolascon A, Sabato V, de Mattia D, Locatelli F. Iolascon A, et al. Among authors: de mattia d. Bone Marrow Transplant. 2001 Jan;27(2):213-5. doi: 10.1038/sj.bmt.1702764. Bone Marrow Transplant. 2001. PMID: 11281393

4

Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation.

Di Bartolomeo P, Di Girolamo G, Angrilli F, Schettini F, De Mattia D, Manzionna MM, Dragani A, Iacone A, Torlontano G. Di Bartolomeo P, et al. Among authors: de mattia d. Bone Marrow Transplant. 1989 Nov;4(6):695-700. Bone Marrow Transplant. 1989. PMID: 2819288

5

CGD associated with cytochrome B deficiency: granulocyte function tests 25 months after bone marrow transplantation.

Manzionna MM, De Mattia D, Fumarulo R, Torlontano G, Schettini F. Manzionna MM, et al. Among authors: de mattia d. Acta Paediatr Hung. 1988-1989;29(1-2):229-32. Acta Paediatr Hung. 1988. PMID: 3076461 No abstract available.

6

Bone marrow transplantation for chronic granulomatous disease associated with cytochrome B deficiency.

Schettini F, De Mattia D, Manzionna MM, Seger RA, Fumarulo R, Torlontano G, Iacone A. Schettini F, et al. Among authors: de mattia d. Pediatr Hematol Oncol. 1987;4(3):277-9. doi: 10.3109/08880018709141279. Pediatr Hematol Oncol. 1987. PMID: 3152933 No abstract available.

7

Factors influencing effectiveness of deferiprone in a thalassaemia major clinical setting.

Del Vecchio GC, Crollo E, Schettini F, Schettini F, Fischer R, De Mattia D. Del Vecchio GC, et al. Among authors: de mattia d. Acta Haematol. 2000;104(2-3):99-102. doi: 10.1159/000039759. Acta Haematol. 2000. PMID: 11154982

8

Management of liver disease in thalassemia: main drug targets for a correct therapy.

Del Vecchio GC, Nigro A, Giordano P, De Mattia D. Del Vecchio GC, et al. Among authors: de mattia d. Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):373-8. doi: 10.2174/156800805774912917. Curr Drug Targets Immune Endocr Metabol Disord. 2005. PMID: 16375691 Review.

9

Bone metabolism in thalassemia major.

Schettini F, Mele M, De Mattia D, Falcone G, D'Addabbo A. Schettini F, et al. Among authors: de mattia d, d addabbo a. J Pediatr. 1987 Jul;111(1):158. doi: 10.1016/s0022-3476(87)80382-7. J Pediatr. 1987. PMID: 3598787 No abstract available.

10

[Oromaxillofacial changes in thalassemia major].

De Mattia D, Pettini PL, Sabato V, Rubini G, Laforgia A, Schettini F. De Mattia D, et al. Minerva Pediatr. 1996 Jan-Feb;48(1-2):11-20. Minerva Pediatr. 1996. PMID: 9072660 Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters